Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...
Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...
Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...
Hims vs. Big Pharma: Is This Telehealth Disruptor the Future of Weight Loss or a Dangerous Shortcut?
Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care products.Hims is part of Hims & Hers Health, a publicly-traded company ...
Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...
Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.
The “Check Before You Inject” ad goes on to note that some vials of compounded semaglutide “have been found to contain ...
Hims & Hers Health (HIMS) stock hits an all-time high as the company's controversial Super Bowl ad is set to air this Sunday ...
Shares of Hims & Hers (HIMS) have jumped on Friday as the company is preparing to air its first Super Bowl ad promoting its compounded ...
The Partnership for Safe Medicines, a pharmaceutical industry group, is asking the U.S. FDA to “take action” against a “dangerous” ad that Hims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results